Claris Lifesciences Inc FDA Record
- Latest inspection NAI · May 18, 2012
- No warning letters matched by name
Claris Lifesciences Inc has 5 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Claris Lifesciences Inc" is on file.
- Latest recall
- D-0127-2018 · Class III · Nov 6, 2017
- Latest inspection
- May 18, 2012 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 5 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 4 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Claris Lifesciences Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Claris Lifesciences Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0127-2018 | Class III | Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100… | Nov 6, 2017 |
| D-0614-2017 | Class II | Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Claris Lifesciences Inc… | Mar 10, 2017 |
| D-0616-2017 | Class II | Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc… | Mar 10, 2017 |
| D-0613-2017 | Class II | Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, Rx only, Manufactured… | Mar 10, 2017 |
| D-0615-2017 | Class II | Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for… | Mar 10, 2017 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 18, 2012 | North Brunswick, NJ | Drugs | No Action Indicated (NAI) | 3007003961 |
| Jun 7, 2010 | North Brunswick, NJ | Drugs | Voluntary Action Indicated (VAI) | 3007003961 |
| Feb 2, 2010 | North Brunswick, NJ | Drugs | Voluntary Action Indicated (VAI) | 3007003961 |
| Jul 13, 2009 | North Brunswick, NJ | Drugs | Voluntary Action Indicated (VAI) | 3007003961 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3007003961 | North Brunswick, NJ | 4 | May 18, 2012 |
Claris Lifesciences Inc and the FDA: common questions
Has Claris Lifesciences Inc received an FDA warning letter?
No FDA warning letter addressed to the name "Claris Lifesciences Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Claris Lifesciences Inc received an FDA Form 483?
FDA has not published a Form 483 for "Claris Lifesciences Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Claris Lifesciences Inc?
The most recent FDA inspection on file ended May 18, 2012 at North Brunswick, NJ and was classified NAI. FDA has 4 inspections of Claris Lifesciences Inc on file.
Has Claris Lifesciences Inc had an FDA recall?
Yes. Claris Lifesciences Inc has 5 FDA recalls on record. The most recent started Nov 6, 2017.
Need more than this page shows? Ask about Claris Lifesciences Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.